Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5

被引:439
|
作者
Dai, MS [1 ]
Lu, H [1 ]
机构
[1] Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, Portland, OR 97201 USA
关键词
D O I
10.1074/jbc.M403722200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncoprotein MDM2 associates with ribosomal proteins L5, L11, and L23. Both L11 and L23 have been shown to activate p53 by inhibiting MDM2-mediated p53 suppression. Here we have shown that L5 also activates p53. Overexpression of L5 stabilized ectopic p53 in H1299 cells and endogenous p53 in U2OS cells. Consequently, L5 enhanced p53 transcriptional activity and induced p53-dependent G(1) cell cycle arrest. Furthermore, like L11 and L23, L5 also remarkably inhibited MDM2-mediated p53 ubiquitination. The interaction of L5 with MDM2 was also enhanced by treatment with a low dose of actinomycin D. Actinomycin D-induced p53 was inhibited by small interference RNA against L5. By reciprocal co-immunoprecipitation, we further showed that there were at least two MDM2-ribosomal protein complexes in cells: MDM2-L5-L11-L23 and p53-MDM2-L5-L11- L23. We propose that the MDM2-L5-L11-L23 complex functions to inhibit MDM2-mediated p53 ubiquitination and thus activates p53.
引用
收藏
页码:44475 / 44482
页数:8
相关论文
共 50 条
  • [1] Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5 (vol 279, 44475, 2004)
    Dai, MS
    Lu, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50)
  • [2] Akt enhances Mdm2-mediated ubiquitination and degradation of p53
    Ogawara, Y
    Kishishita, S
    Obata, T
    Isazawa, Y
    Suzuki, T
    Tanaka, K
    Masuyama, N
    Gotoh, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21843 - 21850
  • [3] TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation
    Bae, Seunghee
    Jung, Jin Hyuk
    Kim, Karam
    An, In-Sook
    Kim, Soo-Yeon
    Lee, Jae Ho
    Park, In-Chul
    Jin, Young-Woo
    Lee, Su-Jae
    An, Sungkwan
    [J]. FEBS LETTERS, 2012, 586 (19) : 3057 - 3063
  • [4] Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination
    O'Keefe, K
    Li, HP
    Zhang, YP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (18) : 6396 - 6405
  • [5] The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation
    Louria-Hayon, I
    Grossman, T
    Sionov, RV
    Alsheich, O
    Pandolfi, PP
    Haupt, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) : 33134 - 33141
  • [6] Mechanistic studies of MDM2-mediated ubiquitination in p53 regulation
    Brooks, Christopher L.
    Li, Muyang
    Gu, Wei
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (31) : 22804 - 22815
  • [7] Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
    Xirodimas, DP
    Stephen, CW
    Lane, DP
    [J]. EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) : 66 - 77
  • [8] HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53
    Wang, Yuhong
    Hu, Lin
    Wang, Jian
    Li, Xiangwei
    Sahengbieke, Sana
    Wu, Jingjing
    Lai, Maode
    [J]. JOURNAL OF PATHOLOGY, 2018, 246 (04): : 508 - 518
  • [9] MdmX protects p53 from Mdm2-mediated degradation
    Jackson, MW
    Berberich, SJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (03) : 1001 - 1007
  • [10] Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination
    Wei, Jinlian
    Yang, Yingrui
    Lu, Mengchen
    Xu, Lili
    Liu, Fang
    Yuan, Zhenwei
    Bao, Qichao
    Jiang, Zhengyu
    Xu, Xiaoli
    Guo, Xiaoke
    Zhang, Xiaojin
    You, Qidong
    Sun, Haopeng
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (02) : 174 - 189